Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer

E-ISSN： 1875-5992|16|4|424-431

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.4, 2016-02, pp. : 424-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 1097-1102

Spandidos Publications

Access to resources Recommend Favorite

Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2354-2358

Spandidos Publications

Access to resources Recommend Favorite

miR320a is an independent prognostic biomarker for invasive breast cancer

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1043-1050

Spandidos Publications

Access to resources Recommend Favorite

Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 53-58

Spandidos Publications

Access to resources Recommend Favorite

miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1153-1161

Spandidos Publications

Access to resources Recommend Favorite